- Home
- EDSA vs PBM Comparison
EDSA vs PBM Comparison
Compare EDSA & PBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDSA
- PBM
- Stock Information
- Founded
- EDSA 2015
- PBM 1994
- Country
- EDSA Canada
- PBM Canada
- Employees
- EDSA N/A
- PBM N/A
- Industry
- EDSA Biotechnology: Pharmaceutical Preparations
- PBM
- Sector
- EDSA Health Care
- PBM
- Exchange
- EDSA Nasdaq
- PBM NYSE
- Market Cap
- EDSA 6.2M
- PBM 5.3M
- IPO Year
- EDSA N/A
- PBM N/A
- Fundamental
- Price
- EDSA $2.43
- PBM $1.30
- Analyst Decision
- EDSA Strong Buy
- PBM
- Analyst Count
- EDSA 1
- PBM 0
- Target Price
- EDSA $21.00
- PBM N/A
- AVG Volume (30 Days)
- EDSA 5.9M
- PBM 367.3K
- Earning Date
- EDSA 02-14-2025
- PBM 02-02-2025
- Dividend Yield
- EDSA N/A
- PBM N/A
- EPS Growth
- EDSA N/A
- PBM N/A
- EPS
- EDSA N/A
- PBM N/A
- Revenue
- EDSA N/A
- PBM N/A
- Revenue This Year
- EDSA N/A
- PBM N/A
- Revenue Next Year
- EDSA N/A
- PBM N/A
- P/E Ratio
- EDSA N/A
- PBM N/A
- Revenue Growth
- EDSA N/A
- PBM N/A
- 52 Week Low
- EDSA $1.55
- PBM $1.15
- 52 Week High
- EDSA $5.59
- PBM $323.25
- Technical
- Relative Strength Index (RSI)
- EDSA 56.54
- PBM 38.56
- Support Level
- EDSA $2.30
- PBM $1.15
- Resistance Level
- EDSA $4.49
- PBM $1.47
- Average True Range (ATR)
- EDSA 0.30
- PBM 0.13
- MACD
- EDSA 0.05
- PBM 0.04
- Stochastic Oscillator
- EDSA 22.56
- PBM 34.09
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.
About PBM PSYENCE BIOMEDICAL LTD
Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.